Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Uwe Simon

Showing results (51-60 of 309) with videos related to

Pageof 31
Sort By:
The Journal of Allergy and Clinical Immunology|October 28, 2008
Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitisSébastien Conus, Alex Straumann, Hans-Uwe Simon
Digestive Diseases (Basel, Switzerland)|March 8, 2014
Eosinophilic esophagitis and allergyDagmar Simon, Alex Straumann, Hans-Uwe Simon
Journal of Molecular Medicine (Berlin, Germany)|December 23, 2014
Protective role of autophagy and autophagy-related protein 5 in early tumorigenesisHe Liu, Zhaoyue He, Hans-Uwe Simon
Autophagy|December 5, 2013
Autophagy suppresses melanoma tumorigenesis by inducing senescenceHe Liu, Zhaoyue He, Hans-Uwe Simon
Cell Death & Disease|December 14, 2020
10 years of Cell Death & DiseaseMauro Piacentini, Yufang Shi, Hans-Uwe Simon
Current Opinion in Immunology|September 18, 2012
Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in diseaseShida Yousefi, Dagmar Simon, Hans-Uwe Simon
Seminars in Cancer Biology|July 9, 2013
Targeting autophagy as a potential therapeutic approach for melanoma therapyHe Liu, Zhaoyue He, Hans-Uwe Simon
The Journal of Allergy and Clinical Immunology|December 13, 2005
Leptin is an eosinophil survival factorSébastien Conus, Andreina Bruno, Hans-Uwe Simon
The Journal of Investigative Dermatology|September 14, 2013
Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?Dagmar Simon, Luca Borradori, Hans-Uwe Simon
Experimental Dermatology|August 24, 2017
Eosinophils as putative therapeutic targets in bullous pemphigoidDagmar Simon, Luca Borradori, Hans-Uwe Simon
Pageof 31

Showing results (51-60 of 309) with videos related to

Sort By:
Pageof 31
The Journal of Allergy and Clinical Immunology|October 28, 2008
Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitisSébastien Conus, Alex Straumann, Hans-Uwe Simon
Digestive Diseases (Basel, Switzerland)|March 8, 2014
Eosinophilic esophagitis and allergyDagmar Simon, Alex Straumann, Hans-Uwe Simon
Journal of Molecular Medicine (Berlin, Germany)|December 23, 2014
Protective role of autophagy and autophagy-related protein 5 in early tumorigenesisHe Liu, Zhaoyue He, Hans-Uwe Simon
Autophagy|December 5, 2013
Autophagy suppresses melanoma tumorigenesis by inducing senescenceHe Liu, Zhaoyue He, Hans-Uwe Simon
Cell Death & Disease|December 14, 2020
10 years of Cell Death & DiseaseMauro Piacentini, Yufang Shi, Hans-Uwe Simon
Current Opinion in Immunology|September 18, 2012
Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in diseaseShida Yousefi, Dagmar Simon, Hans-Uwe Simon
Seminars in Cancer Biology|July 9, 2013
Targeting autophagy as a potential therapeutic approach for melanoma therapyHe Liu, Zhaoyue He, Hans-Uwe Simon
The Journal of Allergy and Clinical Immunology|December 13, 2005
Leptin is an eosinophil survival factorSébastien Conus, Andreina Bruno, Hans-Uwe Simon
The Journal of Investigative Dermatology|September 14, 2013
Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?Dagmar Simon, Luca Borradori, Hans-Uwe Simon
Experimental Dermatology|August 24, 2017
Eosinophils as putative therapeutic targets in bullous pemphigoidDagmar Simon, Luca Borradori, Hans-Uwe Simon
Pageof 31